COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 435: Articles 4341-4350  | Next

Cooperative and structural relationships of the trimeric Spike with infectivity and antibody escape of the strains Delta (B.1.617.2) and Omicron (BA.2, BA.5, and BQ.1)
Souza, A. S. d., de Souza, R. F. R., Guzzo, C. R.
10.1101/2023.03.06.531335 — Posted: 2023-03-06
Immunometabolic rewiring in long COVID patients with chronic headache
Foo, S.-S., Chen, W., Jung, K. L., Azamor, T., Choi, U. Y., Zhang, P., Comhair, S. A., Erzurum, S. C., Jehi, L., Jung, J. U.
10.1101/2023.03.06.531302 — Posted: 2023-03-06
Uncovering strain- and age- dependent differences in innate immune response to SARS-CoV-2 infection in nasal epithelia using combined short and long-read scRNA-seq
Chang, J. J.-Y., Grimley, S., Tran, B., Deliyannis, G., Tumpach, C., Stinear, T. P., Pitt, M. E., Vincan, E., Coin, L. J. M.
10.1101/2023.03.04.531075 — Posted: 2023-03-06
Convergent Evolution of A-Lineage (Clade 19B) SARS-CoV-2 Spike Sequences with B-Lineage Variants of Concern Affects Virus Replication in a Temperature-Dependent Manner on Human Nasal Epithelial Cell Cultures
Yoon, S., Anaya, E. U., Sachithanandham, J., Pinsky, B. A., Sullivan, D. J., Mostafa, H. H., Pekosz, A.
10.1101/2023.03.03.531067 — Posted: 2023-03-06
Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity and neutralization sensitivity
Kumar, S., Delipan, R., Chakraborty, D., Kanjo, K., Singh, R., Singh, N., Siddiqui, S., Tyagi, A., Jha, S., Thakur, K. G., Pandey, R., Varadarajan, R., Ringe, R. P.
10.1101/2023.03.05.531143 — Posted: 2023-03-06
COVID-19 vaccination coverage and linkages with public willingness to receive vaccination prior to vaccine roll-out: Evidence from Rwanda
Ndishimye, P., Sganzerla-Martinez, G., Hewins, B., Toloue Ostadgavahi, A., Kumar, A., Sharma, M., Karuhije, J., Nkeshimana, M., Nsanzimana, S., Kelvin, D.
10.1101/2023.03.05.23286509 — Posted: 2023-03-06
Predicting the feasibility of targeting a conserved region on the S2 domain of the SARS-CoV-2 spike protein
Garg, P., Hsueh, S. C. C., Plotkin, S. S.
10.1101/2023.03.05.531227 — Posted: 2023-03-06
Tau protein aggregation associated with SARS-CoV-2 main protease
Eberle, R. J., Coronado, M. A., Gering, I., Korostov, K., Stefanski, A., Stuehler, K., Kraemer-Schulien, V., Bloemeke, L., Bannach, O., Willbold, D.
10.1101/2023.03.04.531078 — Posted: 2023-03-06
Modelling the association between neutralizing antibody levels and SARS-CoV-2 viral dynamics : implications to define correlates of protection against infection
Lingas, G., Planas, D., Pere, H., Duffy, D., Staropoli, I., Porrot, F., Guivel-Benhassine, F., Chapuis, N., Gobeaux, C., Veyer, D., Delaugerre, C., Le Goff, J., Getten, P., Hadjadj, J., Bellino, A., Parfait, B., Treluyer, J.-M., Schwartz, O., Guedj, J., Kerneis, S., Terrier, B.
10.1101/2023.03.05.23286816 — Posted: 2023-03-06
Post-COVID-19 syndrome and related dysautonomia reduce quality of life, and increase anxiety and depressive symptoms: evidence from Greece
Galanis, P. A., KATSIROUMPA, A., Vraka, I., Kosiara, K., Konstantakopoulou, O., Katsoulas, T., Gallos, P., Kaitelidou, D.
10.1101/2023.03.05.23286811 — Posted: 2023-03-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).